A Phase 3 Study to Evaluate the Efficacy and Long-term Safety of SHR0302 for Induction, Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis.

Project: Research project

Project Details

StatusActive
Effective start/end date1/19/22 → 1/18/27

Funding

  • Reistone Biopharma Company Limited: $11,560.00